When you start on a weight loss journey, it is natural to want to know straight away: how much weight will I actually lose, and how fast? With Wegovy, the honest answer is that it depends on your dose and how long you have been taking it, but the trial evidence behind this weight loss medication gives a genuinely useful picture of what to expect, rather than leaving you guessing.
Table of Contents
1. Understanding Wegovy (Semaglutide)
2. How Much Weight Do People Actually Lose On Wegovy?
3. What Does A Week By Week Timeline Actually Look Like?
4. What Results Should I Expect At 1, 3, 6 And 12 Months?
5. What Actually Affects Your Own Results?
6. How Do Results Compare Across Wegovy's Different Forms?
7. What If I Am Not Losing Weight On Wegovy?
8. What If I Cannot Take Wegovy?
9. Who Can Actually Have Wegovy, And How Does A Prescription Work?
10. Frequently Asked Questions
10.1. How Much Weight Can You Lose On Wegovy In The First Month?
10.2. How Long Does It Take For Wegovy To Work?
10.3. How Much Weight Can You Lose On Wegovy In 3 Months?
10.4. What Is The Average Weight Loss On Wegovy?
10.5. How Much Weight Can You Lose On The Wegovy Pill?
Understanding Wegovy (Semaglutide)
Wegovy is the brand name for semaglutide at the dose licensed specifically for weight management, a GLP-1 receptor agonist that reduces appetite and slows how quickly your stomach empties, helping you feel fuller on less food. It is prescribed alongside a reduced calorie diet and increased physical activity, not as a standalone solution.
People often confuse Wegovy with Ozempic, since both contain semaglutide. Ozempic is licensed in the UK for type 2 diabetes, at a lower maximum dose, while Wegovy is licensed separately for weight management at a higher dose. Some people are prescribed Ozempic off label for weight loss, but Wegovy is the medicine actually evaluated for this purpose in the trial evidence below.
How Much Weight Do People Actually Lose On Wegovy?
In one major clinical trial, people taking Wegovy lost an average of 14.9% of their starting body weight over 68 weeks, compared with 2.4% among those taking a placebo.
These results come from the STEP 1 trial, published in the New England Journal of Medicine. It followed 1,961 adults with obesity, or who were overweight with at least one weight-related health condition, but did not have type 2 diabetes. Participants received weekly semaglutide 2.4 mg or a placebo, alongside changes to their diet and physical activity.
One finding that stood out was that around 32% of participants taking semaglutide lost at least 20% of their starting body weight.
Of course, these figures are averages from a clinical trial, not a promise of what you will lose. Your results may be different depending on your starting weight, dose, lifestyle and how your body responds to treatment.
What Does A Week By Week Timeline Actually Look Like?
Wegovy is introduced gradually rather than starting at the highest dose straight away. This gives your body time to adjust and can make digestive side effects easier to manage.
In the STEP 1 trial, participants followed the same gradual dose escalation schedule used in standard Wegovy treatment today.
| Weeks | Dose |
|---|---|
| 1 to 4 | 0.25 mg |
| 5 to 8 | 0.5 mg |
| 9 to 12 | 1 mg |
| 13 to 16 | 1.7 mg |
| From week 17 | 2.4 mg (standard maintenance dose) |
The first four weeks are not really a treatment dose at all. They exist to let your body adjust before the medicine does any real work, which is exactly why the early weeks tend to disappoint people expecting rapid change.
What Results Should I Expect At 1, 3, 6 And 12 Months?
Modest early on, then building steadily. In the first month, while you are still on the lowest dose, meaningful weight loss is genuinely limited, and this is normal, not a sign anything is wrong. By 3 months, with your dose having increased several times, most people begin noticing a clearer trend. By 6 months, you should have a reasonably good idea of how your body is responding, which is also the point UK guidance uses to check progress properly. By 12 months, many people have been approaching or have reached the kind of results seen in the trial data above, though this varies individually.
What Actually Affects Your Own Results?
There is no single reason why one person loses more weight on Wegovy than another. I would suggest looking at a few things before drawing conclusions about whether your treatment is working.
- Your dose: results at the standard 2.4 mg maintenance dose differ from a lower dose some people remain on due to side effects.
- How consistently you take it: missed or delayed doses affect how steadily the medicine works.
- Diet and activity: the trial itself paired semaglutide with lifestyle changes, not the medicine alone.
- Starting weight: percentage losses and absolute weight losses are not the same thing, and starting point affects both.
How Do Results Compare Across Wegovy's Different Forms?
Broadly similar in direction, though the formulations themselves differ. Wegovy tablets were approved by the MHRA on 11 June 2026, covering adults with obesity (BMI 30 or above) or who are overweight (BMI 27 to 30) with at least one weight related condition, the same broader eligibility used in the STEP 1 trial above. The tablet starts at 1.5 mg daily, increasing to 4 mg, 9 mg and 25 mg, with a minimum of one month at each dose, and must be taken on an empty stomach after an 8 hour fast, swallowed whole with a sip of water, with no food or drink for at least 30 minutes afterwards, since this affects how much is absorbed.
For anyone whose weight loss has plateaued on the standard 2.4 mg injection, Wegovy 7.2 mg is also now available, though its own eligibility is narrower, obesity only, and we have covered its specific trial results and side effects in detail separately.
What If I Am Not Losing Weight On Wegovy?
If you have been taking Wegovy for a while and the scales are barely moving, it is worth discussing this with your prescriber rather than simply waiting for things to change.
UK guidance recommends considering whether to continue semaglutide if you have lost less than 5% of your starting weight after six months of treatment. This gives your prescriber an opportunity to review your progress and consider whether the medicine is working as expected.
It does not mean you have done anything wrong. Your dose, how well you tolerate the medicine and other factors affecting your weight may all need looking at before deciding what to do next.
What If I Cannot Take Wegovy?
Don't worry, there are other options. If Wegovy is not suitable for you, due to an allergy, a contraindication, or simply not getting on with it, other weight loss medicines exist. Mounjaro, which contains tirzepatide, showed average weight reductions of up to around 20.9% at the highest dose in its own 72 week trial, though this comes from a separate study under different conditions, so it is not a direct, like for like comparison with Wegovy's results above. Newer medicines, including retatrutide and survodutide, are still going through clinical trials and are not currently licensed for use in the UK, so they are not yet a genuine alternative, whatever you may have seen claimed elsewhere.
Who Can Actually Have Wegovy, And How Does A Prescription Work?
Wegovy is a prescription-only medicine, so you cannot simply buy it over the counter. Before treatment starts, a clinician needs to assess your weight, medical history and overall health to establish whether it is suitable.
As an online pharmacy based in the UK, we offer clinical consultations and guidance to people interested in Wegovy and similar treatments, helping you work out whether it, or an alternative, genuinely suits your situation, and what to realistically expect in terms of results and timeline. If you want to find out whether Wegovy could be appropriate for you, start your consultation with Pharmacy Planet, and a UK prescriber will review your situation properly.
Weight loss with Wegovy tends to be gradual and sustained rather than immediate, and the rate of progress varies based on individual factors, your dose, and how consistently you follow the lifestyle changes alongside it. Approaching treatment with realistic expectations and staying in touch with your prescriber if results are not what you hoped, gives you the best chance of a result that actually lasts.
Frequently Asked Questions
How Much Weight Can You Lose On Wegovy In The First Month?
Relatively little, since you are only on the lowest, 0.25 mg starting dose during this period. This is intentional, and not a sign the medicine is not working for you.
How Long Does It Take For Wegovy To Work?
Meaningful results typically build over several months as your dose increases, with the trial evidence measuring outcomes at 68 weeks rather than weeks.
How Much Weight Can You Lose On Wegovy In 3 Months?
Individual results vary considerably, but most people are still in the earlier stages of dose escalation at this point, so results are usually still building rather than at their peak.
What Is The Average Weight Loss On Wegovy?
14.9% of starting body weight by 68 weeks in the STEP 1 trial, against 2.4% on placebo, though this is a trial average rather than an individual guarantee.
How Much Weight Can You Lose On The Wegovy Pill?
The tablet contains the same active ingredient as the injection, and is expected to work similarly, though it has its own separate dosing schedule and administration rules.
What Happens If I Am Not Losing Weight On Wegovy?
Speak to your prescriber. UK guidance recommends reviewing treatment if you have lost less than 5% of your starting weight after 6 months, since this is a recognised point to reassess rather than simply continue.
This article is for general information and is not medical advice. Wegovy is a prescription only medicine and is supplied only after a clinical assessment. Trial results are averages and do not predict any individual outcome.
Sources Referenced
- Wilding JPH, Batterham RL, Calanna S, et al; STEP 1 Study Group. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989 to 1002. The source for the headline weight loss figures, the dosing schedule, and the proportion of participants reaching 20% or more weight loss.
- NICE, Semaglutide for managing overweight and obesity (TA875), recommendations, read directly: "Consider stopping semaglutide if less than 5% of the initial weight has been lost after 6 months of treatment"
- Robertson J. MHRA approves semaglutide oral tablets for weight loss. The Pharmaceutical Journal. 12 June 2026. Read in full directly, the source for the Wegovy tablet approval date (11 June 2026), its eligibility criteria, and its dosing and administration rules
- American College of Cardiology, Semaglutide Treatment Effect in People With Obesity - STEP 1, clinical trial summary, cross checked against the primary paper for consistency